Most California insurance plans cover TMS for treatment-resistant depression when the file is clean — but every plan
Most California commercial insurance plans cover TMS for treatment-resistant depression, but every plan requires prior authorization — and
iTBS, cTBS, theta-burst, Express TMS, accelerated iTBS — the naming around theta-burst protocols can confuse even informed patients.
Two FDA-cleared TMS technologies, two different coils, overlapping but distinct indications. A board-certified psychiatric specialist walks through how
TMS is FDA-cleared for depression, OCD, and smoking cessation — but not generalized anxiety disorder. Off-label use is
Forty-six percent of TMS responders are still in response at 12 months without further treatment. For the other
Active TMS treatment runs from 3 to 40 minutes depending on protocol — but the real-world visit time
TMS can hurt, but it does not have to. A board-certified psychiatric specialist explains what TMS actually feels
After two failed antidepressants, the real question is rarely TMS or medication — it is which pathway has
If you have completed both SPRAVATO and TMS without the response you needed, you are not at the
You’ve tried two antidepressants. Now your psychiatrist is talking about Spravato — or TMS. A specialist breaks down
Both Spravato (esketamine) and IV ketamine work fast for treatment-resistant depression. Here’s how they differ in FDA approval,
For most patients with TRD, SPRAVATO and TMS can be combined or sequenced. Here’s what the evidence says
Why Spravato (esketamine) acts in 24 hours when SSRIs take six to eight weeks — and why the
A patient-facing clinical guide to the FDA/EMA two-failed-trials standard for diagnosing treatment-resistant depression — what counts as an
A 2026 clinical guide to treatment-resistant depression: definitions, pseudoresistance workup, evidence-based treatments including SPRAVATO monotherapy, SAINT, and a
